MAPK-Regulated transcription: A continuously variable gene switch?

Nature Reviews Molecular Cell Biology

Volumn 3, Issue 1, 2002, Pages 30-40

  Hazzalin, Catherine A ^a   Mahadevan, Louis C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

ANIMAL; BINDING SITE; BIOLOGICAL MODEL; BIOSYNTHESIS; CHROMATIN; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY; REGULATORY SEQUENCE; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ANIMALS; BINDING SITES; CHROMATIN; GENE SILENCING; IMMEDIATE-EARLY PROTEINS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0036358038     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm715     Document Type: Review

References (120)

1. Cohen, P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol. 7, 353-361 (1997).
2. Kyriakis, J. M. & Avruch, J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-669 (2001).
3. Chen, R.-H., Samecki, C. & Blenis, J. Nuclear localization and regulation of erk+ and rsk-encoded protein kinases. Mol. Cell. Biol. 12, 915-927 (1992).
4. mack) in fibroblasts. J. Cell Biol. 122, 1079-1088 (1993).
5. Wolpert, L. Positional information and the spatial pattern of cellular differenfetion. J. Theor. Biol. 25, 1-47 (1959). The description and development of key concepts.
6. Gurdon, J. B. & Bourillot, P.-Y. Morphogen gradient interpretation. Nature 413, 797-803 (2001).
7. Green, J. B. A. & Smith, J. C. Graded changes in dose of a Xenopus activin A homologue elicit stepwise transitions in embryonic cell fate. Nature 347, 391-394 (1990).
8. Green J. B. A., New, H. V. & Smith, J. C. Responses of embryonic Xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm. Cell 71, 731-739 (1992).
9. Gurdon, J. B., Harger, P., Mitchell, A. & Lemaire, P. Activin signalling and response to a morphogen gradient. Nature 371, 487-492 (1994). References 7-9 are key papers on concentration-dependent effects and thresholds.
10. Traverse, S., Gomez, N., Paterson, H., Marshall, C. & Cohen, P. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288, 351-355 (1992).
11. 1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol. 19, 330-341 (1999).
12. Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185 (1995).
13. Herschman, H. R. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60, 281-319 (1991).
14. McMahon, S. B. & Monroe, J. G. Role of primary response genes in generating cellular responses to growth factors. FASEB J. 6, 2707-2715 (1992).
15. Almendral, J. M. et al. Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol. Cell. Biol. 8, 2140-2148 (1988).
16. Cano, E. Hazzalin, C. A., Kardalinou, E., Buckle, R. S. & Mahadevan, L. C. Neither ERK nor JNK/SAPK MAP kinase subtypes are essential for histone H3/HMG-14 phosphorylation or c-fos and c-jun induction. J. Cell Sci. 108, 3599-3609 (1995).
17. Hazzalin, C.A., Cuenda, A., Cano, E., Cohen, P. & Mahadevan, L. C. Effects of the inhibition of p38/RK MAP kinase on induction of five fos and jun genes by diverse stimuli. Oncogene 15, 2321-2331 (1997).
18. Hazzalin, C. A., Le Panse, R. Cano, E & Mahadevan, L. C. Anisomycin selectively desensitizes signalling components involved in stress kinase activation and fos and jun induction. Mol. Cell. Biol. 18, 1844-1854 (1998).
19. Nakabeppu, Y. Ryder, K. & Nathans, D. DNA-binding activities of 3 murine Jun proteins: stimulation by Fos. Cell 55, 907-916 (1988).
20. Halazonetis, T. D., Georgopoulos, K., Greenberg., M. E. & Leder, P. c-Jun dimerises with itself and c-fos forming complexes of differing DNA-binding affinities. Cell 55, 917-924 (1988).
21. Ryseck, R.-P. & Bravo, R. c-Jun, Jun B, and Jun D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of Fos proteins. Oncogene 6, 533-542 (1991).
22. Hai, T. & Curran, T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl Acad. Sci. USA 88, 3720-3724 (1991).
23. Karin, M., Liu, Z. G. & Zandi, E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240-246 (1997).
24. 1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol. Cell. Biol. 11, 2451-2459 (1991).
25. 1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins. Mol. Cell. Biol. 12, 5015-5023 (1992). References 19-25 describe the complexity of AP-1 composition and specificity.
26. Smith, S. et al. Molecular approaches to vertebrate limb morphogenesis. Development (Suppl.) 107, 121-131 (1989).
27. Cochran, B. H., Reffel, A. C. & Stiles, C. D. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33, 939-947 (1983).
28. Greenberg, M. E. & Ziff, E. B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311, 433-438 (1984).
29. Lau, L. F. & Nathans, D. Expression of a set of growth-related immediate-early genes in BALB/C3T3 cells: coordinate regulation with c-fos or c-myc. Proc. Natl Acad. Sci. USA 84, 1182-1186 (1987).
30. Herrera, R. E., Shaw, P. E. & Nordheim, A. Occupation of the c-fos serum response element in vivo by a multi-protein complex is unaltered by growth factor induction. Nature 340, 68-70 (1989).
31. Herr, I., van Dam, H. & Angel, P. Binding of promoter-associated AP-1 is not altered during induction and subsequent repression of the c-jun promoter by TPA and UV irradiation. Carcinogenesis 15, 1105-1113 (1994).
32. Rozek, D. & Pfeifer, G. P. In vivo protein-DNA interactions at the c-jun promoter in quiescent and serum-stimulated fibroblasts. J. Cell. Biochem. 57, 479-487 (1995).
33. Phair, R. D. & Misteli, T. High mobility of proteins in the mammalian cell nucleus. Nature 404, 604-609 (2000).
34. McNally, J. G., Muller, W. G., Walker, D., Wolford, R. & Hagar, G. L. The glucocorticoid receptor rapid exchange with regulatory sites in living cells. Science 287, 1262-1265 (2000). References 33 and 34 are recent descriptions of dynamic movement of proteins in the nucleus studied in vivo.
35. Wagner, B. J., Hayes, T. E., Hoban, C. J. & Cochran, B. H. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J. 9, 4477-1484 (1990).
36. Sadowkis, H. B., Shuai, K., Damell, J. E. Jr. & Gilman, M. Z. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261, 1739-1744 (1993).
37. Fu, X.-Y. & Zhang, J. J. Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell 74, 1135-1145 (1993).
38. Karin, M. & Hunter, T. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 5, 747-757 (1995).
39. Treisman, R. Regulation of transcription by MAP kinase cascades. Curr Opin. Cell Biol. 8, 205-215 (1996).
40. Chang, L. & Karin, M. Mammalian MAP kinase signalling cascades. Nature 410, 37-40 (2001).
41. Sharrocks, A. D., Yang, S. H. & Galanis, A. Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem. Sci. 25, 448-453 (2000).
42. Dérijard, B. et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037 (1994).
43. Boulton, T. G. et al. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65, 663-675 (1991).
44. Kyriakis, J. M. et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156-160 (1994).
45. Han, J., Lee, J.-D., Bibbs, L. & Ulevitch, R. J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811 (1994).
46. Rouse, J. et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78, 1027-1037 (1994).
47. Freshney, N. W. et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78, 1039-1049 (1994).
48. Lee, J. C. et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746 (1994). This is a seminal paper on p38 MAPK and its inhibitors.
49. Zhou, G., Bao, Z. Q. & Dixon, J. E. Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 270, 12665-12669 (1995).
50. Lee, J.-D., Ulevitch, R. J. & Han, J. Primary structure of BMK1 : a new mammalian MAP kinase. Biochem. Biophys. Res. Commun, 213, 715-724 (1995).
51. Bagowski, C. & Ferrell, J. Bistability in the JNK cascade Curr. Biol. 11, 1176-1182 (2001).
52. Ferrell, J. E. How regulated protein translocation can produce switch-like responses. Trends Biochem. Sci. 23, 461-465 (1998).
53. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J. & Saltiel, A. R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl Acad. Sci. USA 92, 7686-7689 (1995). This was the first description of an inhibitor of ERK/MAPK cascade.
54. Davies, S. P., Reddy, H., Caivano, M. & Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105 (2000).
55. Price, M. A., Cruzalegui, F. H. & Treisman, R. The p38 and ERK MAP kinase pathways cooperate to activate ternary complex factor and c-fos transcription in response to UV light. EMBO J. 15, 6552-6563 (1996).
56. Hazzalin, C. A. et al. p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient. Curr. Biol. 6, 1028-1031 (1996).
57. Han, T.-H & Prywes, R. Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol. Cell. Biol. 15, 2907-2915 (1995).
58. Han, J., Jiang, Y., Li, Z., Kravchenko, V. V. & Ulevitch, R. J. MEF2C participates in inflammatory responses via p38-mediated activation. Nature 386, 563-566 (1997).
59. Gupta, S., Campbell, D., Derijard, B. & Davis, R. J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267, 389-393 (1995).
60. Raingeaud, J. et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420-7426 (1995).
61. van Dam, H. et al. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14, 1798-1811 (1995).
62. Livingstone, C., Patel, G. & Jones, N. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14, 1785-1797 (1995).
63. Rivera, V. M. et al. A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity. Mol. Cell. Biol. 13, 6260-6273 (1993).
64. Gilie, H. et al. ERK phosphorylation potentiates Bk-1-mediated ternary complex formation and transactivation. EMBO J. 14, 951-962 (1995).
65. Marais, R., Wynne, J. & Treisman, R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73, 381-393 (1993). This is definitive work that links ERK/MAPK and Elk-1 to c-fos transcriptional activation.
66. Whitmarsh, A. J., Snore, P., Sharrocks, A. D. & Davis, R. J. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269, 403-407 (1995).
67. Whitmarsh, A. J., Yang, S. H., Su, M. S., Sharrocks, A. D. & Davis, R. J. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell. Biol. 17, 2360-2371 (1997).
68. Raingeaud, J., Whitmarsh, A. J., Barrett, T., Dérijard, B. & Davis, R. J. MKK3-and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16, 1247-1255 (1996). References 57-68 describe various direct MAPK-transcription factor relationships and their role in gene induction.
69. Deak, M., Clifton, A. D., Lucocq, J. M. & Alessi, D. R. Mitogen-and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38 and may mediate activation of CREB. EMBO J. 17, 4426-4441 (1998).
70. Arthur, J. S. C. & Cohen, P. MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells. FEBS Lett 482, 44-48 (2000).
71. Kuo, M. H. & Allis, C. D. Roles of histone acetylation and deacetylatton in gene regulation. Bioessays 20, 615-626 (1998).
72. Sterner, D. E. & Berger, S. L Acetylation of histones and transcription related factors. Microbiol. Mol. Biol. Rev. 64, 435-459 (2000).
73. Arias, J. et al. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370, 226-229 (1994).
74. Bannister, A. J. & Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature 384, 641-643 (1996).
75. Kouzarides, T. Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9, 40-48 (1999).
76. Yang, X. J., Ogryzko, V. V., Nishikawa, K., Howard, B. H. & Nakatani, Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319-324 (1996). References 74 and 76 report on the discovery of histone acetyttransferase (HAT) activity of coactivators
77. Kawasaki, H. et al. ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature 405, 195-200 (2000).
78. Wies, R. G. et al. A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300. EMBO J. 20, 6095-6103 (2001).
79. Thomson, S., Clayton, A. L. & Mahadevan, L. C. Independent dynamic regulation of histone phosphorylation and acetylation during immediate-early gene induction. Mol. Cell 8, 1231-1241 (2001).
80. Alberts, A. S., Geneste, O. &Treisman, R. Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation. Cell 92, 475-487 (1998). This is a key paper on MAPKs in the context of histone acetylation during immediate-earry gene induction.
81. Mahadevan, L. C., Willis, A. C. & Barratt, M. J. Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell 65, 775-783 (1991).
82. Chadee, D. N. et al. Increased Ser-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene-transformed mouse fibroblasts. J. Biol. Chem. 274, 27914-24920 (1999).
83. Barratt, M. J., Hazzalin, C. A., Zhelev, N. & Mahadevan, L. C. A mitogen-and anisomycin-stimulated kinase phosphorylates HMG-14 in its basic amino-terminal domain in vivo and on isolated mononucleosomes. EMBO J. 13, 4524-4535 (1994).
84. Sassone-Corsi, P. et al. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 285, 886-891 (1999).
85. Clayton, A. L., Rose, S., Barratt, M. J. & Mahadevan, L. C. Phosphoacetylation of histone H3 on c-fos and c-jun-associated nucleosomes upon gene activation. EMBO J. 19, 3714-3726 (2000).
86. Cheung, P. et al. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol. Cell 5, 905-915 (2000).
87. Thomson, S. et al. The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 is a potential histone H3/HMG-14 kinase. EMBO J. 18, 4779-4793 (1999).
88. Rutault, K., Hazzalin, C. A. & Mahadevan, L. C. Combinations of ERK and p38 MAPK inhibitors ablate TNF-a mRNA induction: evidence for selective destabilisation of TNF-α transcripts. J. Biol. Chem. 276, 6666-6674 (2001).
89. Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A. & Brown, M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843-852 (2000).
90. Gurdon, J. B. et al. Single cells can sense their position in a morphogen gradient. Development 126, 5309-5317 (1999).
91. Van Craenenbroeck, K., Vanhoenacker, P. & Haegeman, G. Episomal vectors for gene expression in mammalian cells. Eur. J. Biochem. 267, 5665-5678 (2000).
92. Hazzalin, C. A. Mitogen-and anisomycin-stimulated induction of immediate-early genes. Thesis, Univ. London, UK (1996).
93. Zervos, A. S., Faccio, L., Gatto, J. P., Kyriakis, J. M. & Brent, R. Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. Proc. Natl Acad. Sci. USA 92, 10531-10534 (1995).
94. Treisman, R. The serum response element. Trends Biochem. Sci. 17, 423-426 (1992).
95. Hayes, T. E., Kitchen, A. M. & Cochran, B. H. Inducible binding of a factor to the c-fos regulatory region. Proc. Natl Acad. Sci. USA 84, 1272-1276 (1987).
96. Shaw, P. E. Schröter, H. & Nordheim, A. The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter. Cell 56, 563-572 (1989).
97. Sassone-Corsi, P., Visvader, J., Ferland, L, Mellon, P. L. & Verma, I. M. Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes Dev. 2, 1529-1538 (1988).
98. Fisch, T. M., Prywes, R. & Roeder, R. G. An AP1-binding site in the c-fos gene can mediate induction by epidermal growth factor and 12-O-tetradecanoylphorbol-13-acetate. Mol. Cell. Biol. 9, 1327-1331 (1989).
99. Fisch, T. M., Prywes, R. & Roeder, R. G. c-fos sequences necessary for basal expression and induction by epidermal growth factor, 12-O-tetradecanoyl phorbol-13-acetate, and the calcium ionophore. Mol. Cell. Biol. 7, 3490-3502 (1987).
100. Sheng, M., Dougan, S. T., McFadden, G. & Greenberg, M. E. Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol. Cell. Biol. 8, 2787-2796 (1988).
101. Lazo, P. S., Dorfman, K., Noguchi, T., Mattéi, M.-G. & Bravo, R. Structure and mapping of the fosB gene. FosB downregulates the activity of the fosB promoter. Nucleic Acids Res. 20, 343-350 (1992).
102. Angel, P., Hattori, K., Smeal, T. & Karin, M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55, 875-885 (1988).
103. Han, T.-H, Lamph, W. W. & Prywes, R. Mapping of epidermal growth factor-, serum-, and phorbol ester-responsive sequence elements in the c-Jun promoter. Mol Cell. Biol. 12, 4472-4477 (1992).
104. de Groot, R. P., Auwerx, J., Karperien, M., Staels, B. & Kruijer, W. Activation of junB by PKC and PKA signal transduction through a novel cis-acting element. Nucleic Acids Res. 19, 775-781 (1991).
105. Perez-Albueme, E. D., Schatteman, G., Sanders, L. K. & Nathans, D. Transcriptional regulatory elements downstream of the JunB gene. Proc. Natl Acad. Sci. USA 90, 11960-11964 (1993).
106. Phinney, D. G., Keiper, C. L. Francis, M. K. & Ryder, K. Quantrtative analysis of the contribution made by 5′-flanking and 3′-flanking sequences to the transcriptional regulation of junB by growth factors. Oncogene 9, 2353-2362 (1994).
107. Coffer, P. et al. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2. Oncogene 9, 911-921 (1994).
108. de Groot, R. P., Karperien, M., Pals, C. & Kruijer, W. Characterization of the mouse junD promoter-high basal level activity due to an octamer motif. EMBO J. 10, 2523-2532 (1991).
109. Galanis, A., Yang, S. H. & Sharrocks, A. D. Selective targeting of MAPKs to the ETS domain transcription factor SAP-1. J. Biol. Chem. 276, 965-973 (2001).
110. Waskiewicz, A. J., Flynn, A., Proud, C. G. & Cooper, J. A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16, 1909-1920 (1997).
111. Fukunaga, R. & Hunter, T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16, 1921-1933 (1997).
112. Frodin, M. & Gammeltoft, S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol. 151, 65-77 (1999).
113. Gille, H., Strahl, T. & Shaw, P. E. Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr. Biol. 5, 1191-1200 (1995).
114. Wang, X. Z. & Ron, D. Stress-induced phosphorylation and activation of the transcription factor CHOP (+GADD153) by p38 MAP kinase. Science 272, 1347-1349 (1996).
115. Zhao, M. et al. Regulation of the MEF2 family of transcription factors by p38. Mol. Cell. Biol. 19, 21-30 (1999).
116. Stokoe, D. et al. MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. EMBO J. 11, 3985-3994 (1992).
117. McLaughlin, M. M. et al. Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP/p38 MAP kinase. J. Biol. Chem. 271, 8488-8492 (1996).
118. New, L. et al. PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J. 17, 3372-3384 (1998).
119. Kato, Y. et al. BMK/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16, 7054-7066 (1997).
120. Chen, R.-H., Abate, C. & Blenis, J. Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc. Natl Acad. Sci. USA 90, 10952-10956 (1993).